| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $55K | +0.0% |
| R&D Expense | $10.8M | -6.3% |
| SG&A Expense | $9.6M | -11.4% |
| Operating Income | -$20.4M | +8.5% |
| Pre-tax Income | -$19.9M | +10.4% |
| Income Tax | $537K | +577.2% |
| Net Income | -$20.4M | +8.3% |
| EPS (Basic) | -$0.89 | +48.0% |
| EPS (Diluted) | -$0.89 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.4M | -11.9% |
| Short-term Investments | $5.0M | +0.0% |
| Current Assets | $11.6M | -34.7% |
| Total Assets | $12.1M | -34.9% |
| Current Liabilities | $3.9M | -21.0% |
| Long-term Debt | $439K | -22.8% |
| Total Liabilities | $4.8M | -20.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.9M | -0.0% |
| Investing Cash Flow | $5.0M | -51.3% |
| Financing Cash Flow | $13.0M | +2.9% |
| +48.0% |
| Stockholders' Equity |
| $7.3M |
| -41.6% |